Dr. Russell Sharp explores how widespread use of GLP‑1 weight‑loss drugs (soon available orally) could reduce overall calorie intake and shift demand across crop types. He outlines the likely big losers (corn/maize, soybeans, sugar, palm oil) and relative winners (pulses, fibre‑rich fruits and vegetables, premium proteins), as well as crops likely to remain stable (rice, wheat, tubers) and non‑food crops largely unaffected.
The episode discusses implications for hydroponics and horticulture, potential changes in the food and leisure industries, and cautions about drug side effects and broader societal impacts.
https://eutrema.co.uk/shop/fertiliser/liquid-gold-unique-complete-fertiliser/
Liraglutide Victoza,  Saxenda 
Semaglutide, Ozempic, Wegovy
Tirzepatide Mounjaro 


Robbie Williams, Greggs the baker, McDonalds, KFC, Wendy's, Chick-fil-a, chipotle, beyond meat, impossible foods, subway, waitrose, tesco, sainsbury's, asda, aldi, lidl, hyrox, crossfit, turf games, park run, personal trainers, david lloyd gyms, jd sports, jd gyms, virgin active, vitality insurance, 

Ver todos los episodios